Financials
Financial year 2025
JULIE JACOBS KLINISCH BIOLOOG from Tervuren, company number BE0716718944, closed financial year 2025 with a result of € 86,275 after tax. For that financial year JULIE JACOBS KLINISCH BIOLOOG recorded a gross margin of € 207,304 and equity of € 67,359. Compared with financial year 2024, the result moved from € 7,166 to € 86,275. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 67,359
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 86,275
▲ € 79,109 vs 2024
Profit after tax over the fiscal year.
€ 126,275
▲ 123% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 86,275 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 13,545
▼ 39% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 8,028
▲ 1% vs 2024
Loans from banks and other lenders, long and short.
€ 1,103
▲ 212% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,638
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 165,327 | € 168,372 | € 134,756 | € 207,304 | ▲ 54% |
| Profit after taxes | € 117,209 | € 120,845 | € 7,166 | € 86,275 | ▲ € 79,109 |
| Equity | € 316,877 | € 67,359 | € 67,359 | € 67,359 | |
| Total debts | € 22,432 | € 137,577 | € 17,934 | € 78,709 | ▲ € 60,775 |
| Cash | € 203,445 | € 107,342 | € 56,738 | € 126,275 | ▲ 123% |
| Retained profit | € 298,277 | € 48,759 | € 48,759 | € 48,759 | |
| Dividend | € 0 | € 370,363 | € 7,166 | € 86,275 | ▲ € 79,109 |
| Bank debt | € 8,333 | € 8,457 | € 7,912 | € 8,028 | ▲ 1% |
| Balance sheet total | € 339,309 | € 204,937 | € 175,526 | € 238,842 | ▲ 36% |
Key figures of JULIE JACOBS KLINISCH BIOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to JULIE JACOBS KLINISCH BIOLOOG?
What happened at JULIE JACOBS KLINISCH BIOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 86,275 (▲ € 79,109 vs 2024). Source: NBB ↗
- New establishment in Etterbeek. KBO
- Julie Jacobs became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 117,209 profit in 2022 to € 86,275 profit in 2025.
Paid € 131,893 in corporate taxes since 2022.
Best year ever: 2023, with € 120,845 profit.
Paid out € 463,804 in dividends to the owners in total.
Management
Behind JULIE JACOBS KLINISCH BIOLOOG is Julie Jacobs.
Directors
According to the 2025 annual accounts
Julie Jacobs
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Smisstraat 67
3080 Tervuren
Louis Schmidtlaan 2/D/b4
1040 Etterbeek
Active since 20 December 2018
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0716.718.944
- VAT number
- BE 0716.718.944
- Registered office
- Smisstraat 67, 3080 Tervuren
- Names & denominations
- JULIE JACOBS KLINISCH BIOLOOG
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 2018
- Peppol
- Active · Active since 14 Oct 2025